Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (126)

Date

2021 (19)
2020 (55)
2019 (6)
2018 (34)
2017 (12)

Results for "[search-keyword]"

Search

Sponsor content

126 result(s) found, displaying 91 to 100

VOLTADINE TENSION HEADACHE capsule-shaped tablet blister pack Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
VOLTADINE TENSION HEADACHE capsule-shaped tablet sachet Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
FIORINAL Tablets blister pack Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
FIORINAL DENTAL capsule blister pack Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
OILATUM Plus Concentrated Bath Emollient Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
ACNE AID Medicated Bar Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
LACTICARE Lotion Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
OILATUM Bath Emollient Liquid Paraffin BP 542.07mg/mL lotion bottle Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PanOxyl Acnegel 10 Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PanOxyl Acnegel 5 Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Pages

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.